Search
兒童疫苗

Childhood Vaccination Programme

The current free childhood vaccination programme at government maternal and child health centres can only effectively prevent some infectious diseases, and does not provide preventative vaccines for certain high-risk and fatal infectious diseases. Our centre offers vaccines not provided by maternal and child health centres to give babies the most comprehensive protection! The "Children's Vaccination and Health Plan" at Wai-yue ensures all vaccinations are administered by paediatric specialists, providing comprehensive health and preventative injections for infants and young children at different stages of growth and development. Before each vaccination, a doctor will perform a basic physical examination on your baby.

Is pneumonia easily overlooked? Children's infections can be fatal

According to the World Health Organisation (WHO) estimates,Globally, around 1 million children under the age of five die each year from pneumococcal infections.In Hong Kong, there are also occasional cases of young children suffering from severe pneumonia. Because children's immune systems are not yet fully developed and their immunity is lower than adults, children under one year of age are at a 25.9 times higher risk of infection!

Leading to a number of serious complications, including:
Pneumonia, Sepsis, Sinusitis, Acute, Otitis Media, Meningitis

Children are at a higher risk of death from pneumococcal disease than adults. In addition to maintaining good personal hygiene habits and ensuring children get enough sleep and rest, we should seize the opportunity to have them vaccinated as soon as possible.
Pneumococcal conjugate vaccines suitable for children available on the market include 13-valent, 15-valent, and the latest upgraded 20-valent pneumococcal conjugate vaccine!

Hui'er has now introduced the latest20-valent pneumococcal vaccineCompared to the previous 13-valent vaccine, this vaccine can prevent more serotypes of pneumococcus, offering broader protection for infants and young children.

This new vaccine covers an additional 7 serotypes, preventing more strains that can cause invasive pneumococcal disease, including serious illnesses such as pneumonia, meningitis, and septicaemia. Vaccination recommendations and dosage schedules will vary based on individual age and health status.

Number of vaccine doses

Infants aged 6 weeks to 15 months:A total of four stitches
Children aged 2 years and over and adults:One stitch

Pneumococcal vaccines are prescription-only medications. Effectiveness and side effects may vary depending on the user's physical condition and individual symptoms. Please consult your doctor or pharmacist for details.
Fully upgraded vaccines, with stronger protection, offering broader protection for children! Hui Er Paediatrics provides childhood immunisation services, where your child will be vaccinated by professional medical staff, ensuring safety and reliability.

This information is provided by Pfizer.
References:
a. Pneumococcal polysaccharide conjugate, 20-valent adsorbed, Prescribing Information.
Pfizer Corporation Hong Kong Limited: Version July 2024.
b. CHP. Report on IPD. Available at: www.chp.gov.hk/en/resources/29/636.html.
Accessed December 2024.
c. Ladhani SN, et al. Lancet Infect Dis2018;18:441-451.

Pneumonia is the second leading cause of death in Hong Kong.

According to the World Health Organisation, pneumococcal disease poses an increasing threat to people worldwide, and anyone of any age can be infected with pneumococcal bacteria. Pneumococcal bacteria are highly contagious and can hide in the nasopharynx, waiting for an opportunity to invade the body, and can also cross-infect young children at home. In addition to causing pneumonia, they can also cause a variety of serious diseases, such as pneumonia, meningitis, otitis media, and septicaemia, and even death. Of these, regarding pneumonia, one in every six people globally5children under the age of1Pneumonia is the second leading cause of death in Hong Kong.

Vaccination is currently one of the most effective ways to prevent pneumococcal disease. However, there are over100The most important thing is that the vaccine targets the correct serotype! 2009Since [Year], the Department of Health has included the pneumococcal vaccine in the "Hong Kong Childhood Immunisation Programme". However, in Hong Kong there are45%-68%Invasive pneumococcal disease is caused by the serum, considered the number one killer of invasive pneumococcal disease.3Type-induced. Currently in Hong Kong, they use13Pneumococcal vaccine for serotypes3The type protection is low and cannot offer complete resistance.

New generation15Pneumococcal vaccine

Earlier than2021Year7The moon can be used for18Adults aged [number] and over15Pneumococcal vaccine, approved by the USAFDAApproval for expanded use, next-generation15Pneumococcal vaccine Now available from birth6For infants and young children over a week old. Utilising a unique technology to improve efficacy and induce a stronger immune response, it has been approved for use in European and American countries such as the United States, United Kingdom, Canada, and Australia.

  • Precise serum targeting3Pneumococcal type
  • Prevention15Serotype of pneumococcus(1,3,4,5,6A,6B,7F,9 volts,14,18th century,19A,19F,22F,23F,33F;
  • Compared with the existing vaccine (13-valent), it offers a full 73% greater immunogenicity;
  • Approved for use by the US FDA and the EU

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health

What is rotavirus?

Rotaviruses are named for their wheel-like appearance under an electron microscope. Rotaviruses are highly contagious and can persist on objects and in the environment. Even a small amount of the virus can cause illness in babies and is the most common viral cause of acute gastroenteritis, leading to fever, vomiting, severe diarrhoea, and dehydration. Diarrhoea can be severe and last for 7-10 days, with some cases resulting in severe dehydration, particularly in infants. Rotaviruses pose the greatest risk to the youngest infants.Almost all children have been infected with rotavirus before the age of 5.After recovering from the first infection, lifelong immunity will not be developed, so there is a chance of reinfection.
 

Rotavirus vaccine

There is currently no cure for rotavirus, and medication can only help alleviate symptoms, such as fluid replacement via intravenous drip and temperature control. Prevention is better than cure, so vaccination is the most effective way to prevent rotavirus. Vaccination can effectively reduce the chance of infection and also lower the chance of hospitalisation due to it (rotavirus infection is one of the most common reasons for children to be admitted to hospital). In Hong Kong, babies can be vaccinated from 6 weeks old. Due to age restrictions, vaccination must be started and completed within a specified timeframe.
 

Understanding Rotavirus at a Glance

兒童疫苗
 

Recommended vaccination time

Rotavirus vaccine, oral, 2 doses Rotarix (RV1) – GSK

  • Including the most common rotavirus serotype G1P[8]
  • Recommended for 2 doses at: 2 months and 4 months of age
  • Must be completed within 24 weeks of birth

Oral Rotavirus Vaccine, 3 doses, RotaTeq (RV5) – MSD

  • Including the five most common rotavirus serotypes: G1, G2, G3, G4 and P1A[8]
  • Recommended for 3 doses at: 2, 4, and 6 months of age
  • Must be completed within 32 weeks of birth.

[Previous episode] Rotavirus a high risk in winter, young children with vomiting and diarrhoea have no cure | Dr. Wu Chun-pun

 

[Next Episode] Rotavirus a High Risk in Winter, Infants Vomiting and Diarrhoea Without Medical Treatment | Dr. Wu Chun-pan

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health

Meningococcal bacterium

Meningococcal disease is an illness caused by the bacterium *Neisseria meningitidis*. It is a serious, acute infectious disease that can be transmitted through secretions from the nose and mouth of an infected person. Close contact and interaction among children at school can easily lead to cross-infection. Newborns whose immune systems are immature, young children, adolescents, and people visiting areas with high incidence rates are also at high risk, with the highest incidence rate among infants aged 0 to 3 months. Early symptoms are not obvious and are very similar to those of a common cold. When the bacteria invade the bloodstream (meningococcal septicaemia) or the membranes surrounding the brain and spinal cord (meningitis), it can lead to severe conditions, causing patients to develop fever and shock. In severe cases, it can be fatal within 24 hours.

 

There are two main categories of pathogens that cause meningitis:

  1. Bacteria: *Neisseria meningitidis*, *Haemophilus influenzae*, *Streptococcus pneumoniae*. Bacterial meningitis is a particularly serious illness that requires prompt treatment.
  2. Viruses: Enterovirus, Herpes simplex virus

腦膜炎病原體

Meningitis symptoms:

  • Meningococcal septicaemia (bacteria invading the bloodstream)
      • Sudden fever
      • Headache
      • Bruise
      • Shock
      • Severe and potentially fatal
  • Meningitis (infection of the membranes surrounding the brain and spinal cord):
      • High fever
      • Severe headache
      • Stiff neck
      • Vomiting
      • Photophobia
      • Rash
      • It can cause serious brain damage, such as intellectual impairment.
      • Can be fatal in severe cases

Meningococcal ACWY conjugate vaccine

Infants and young children have lower immunity, so to more comprehensively prevent meningococcal infection, two types of vaccines are required:

  1. Meningococcal ACWY conjugate vaccineCapable of covering 4 serotypes, it can prevent meningococcal meningitis types A, C, Y, and W, and prevents diseases caused by meningococcal meningitis.
  2. Meningococcal B vaccine (MenB)Can prevent B-type meningococcal infection

Suggested injection time

Meningococcal (quadrivalent) conjugate vaccine Menactra – Sanofi

  • 9-23 months: Two doses (3 months apart)

  • Aged 2 to 55: One dose

  • Ages 15 to 24: After four years since the first dose, receive one booster dose.

Meningococcal group B vaccine Nimenrix – Pfizer

  • 2 months - 4 months - 12 months: 3 injections in total

  • 3 months - 5 months - 12 months: 3 doses in total

  • 12 months: 1 dose

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health

What is meningococcal disease serogroup B

Meningococcal bacteria have many different serogroups, generally divided into six types: A, B, C, W, X, and Y. Most cases are caused by infection with serogroups A, B, C, W, and Y, withType B accounts for nearly 50% of infections in Hong Kong.

Meningococcal type B can cause invasive meningitis, which progresses rapidly; once infected, patients may die within 24 hours of the onset of symptoms, with a mortality rate as high as 10%.One in five patients may suffer serious long-term complications, including blindness, deafness and intellectual impairment, or may even require amputation. Meningococcal meningitis (MEN-B) is like an invisible killer, lurking in one in ten people.As the symptoms resemble those of a common cold, parents generally find it difficult to detect the condition; they often only realise something is wrong when their child develops purpura all over their body – by which time it is already too late!

Meningococcal group B vaccine

Early meningococcal vaccines only covered serogroups A, C, W and Y, and did not provide protection against cases caused by serogroup B; it was not until 2019 that the meningococcal B vaccine was finally introduced in Hong Kong.According to the US Centres for Disease Control and Prevention (CDC), vaccination is effective in reducing infections caused by meningococcal serogroup B (MEN-B). Vaccination boosts children’s immunity, helping them to fight off MEN-B infections; studies show that the protection rate reaches 95–100 per cent,Parents are advised to ensure their children are prepared.

Understanding Meningococcal Group B in one chart

B型腦膜炎雙球菌疫苗

 

Recommended vaccination time

Meningococcal Group B vaccine (Men-B) Bexsero – GSK

  • 2 months: 4 doses in total (first 3 doses should ideally be at least 1 month apart, booster dose to be administered at 12 months or older *at least 6 months after the 3rd dose)
  • 3 – 5 months: 3 doses in total (a minimum of 2 months between the first 2 doses, with the booster administered at 12 months or older *with a minimum of 6 months between the 2nd and booster doses)
  • 6-11 months: 3 doses in total (first 2 doses recommended to be at least 2 months apart, booster to be administered at 12 months or older *at least 2 months after the 2nd dose)
  • 12 – 23 months: 3 doses in total (the first 2 doses should be at least 2 months apart, and the booster dose should be administered within 12–23 months after the second dose)
  • 2 years and over: 2 doses (minimum 1 month between doses) 

Encourage vaccinationGroup B meningitisVaccination Programme | Dr. Chan Yick-Chun

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health
 

What is Japanese encephalitis

Japanese encephalitis virus is transmitted to humans by infected mosquitoes. Most people infected with the Japanese encephalitis virus do not show symptoms, and approximately one in 250 infected individuals will develop severe Japanese encephalitis symptoms, including neurological disorders, psychological disorders, intellectual problems, and physical disabilities.

 

Japanese encephalitis vaccine

There are currently no specific antiviral drugs available to treat Japanese encephalitis; doctors can only provide supportive care to alleviate symptoms and stabilise the patient’s condition. The World Health Organisation recommends that vaccination against Japanese encephalitis be considered if factors indicating the transmission of the disease are present locally or in neighbouring areas.Infants aged 9 to 18 months (99.2%) are protected 28 days after receiving one dose of the Japanese encephalitis vaccine.

 

Recommended vaccination time

  • 9 months to 17 years: Two doses (12-24 months apart)
  • 18 and over: One dose

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health

What is hepatitis A

Hepatitis A is a serious liver disease caused by the Hepatitis A virus, which is a filterable virus that spreads from person to person through contact with the faeces of an infected person. Hepatitis A can lead to liver failure and death. Infected individuals may have no symptoms or only mild flu-like or gastrointestinal symptoms, but it can cause acute hepatitis, with symptoms such as fever, fatigue, and jaundice. Most patients are asymptomatic during childhood, but the symptoms gradually emerge upon reaching adulthood.

Hepatitis A vaccine

Since it is possible to transmit hepatitis A even without symptoms, vaccination is an effective way to prevent infection. Since 1996, the United States has recommended that citizens receive the hepatitis A vaccine. Since then, the number of reported cases in the United States has decreased from approximately 31,000 to less than 1,500 annually.

Recommended vaccination time

  • Aged 1 year or over: 2 doses (at least 6 months apart)

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health

Benefits of the 6-in-1 vaccine

Combining multiple vaccines significantly reduces the number of injections, and can also decrease the chance of side effects and discomfort in infants and children after vaccination.

The hexavalent vaccine protects against six diseases.

  • DiphtheriaCaused by *Corynebacterium diphtheriae*, it is a serious bacterial infection affecting the nose and throat.
  • Whooping coughCaused by the bacterium pertussis, it is a serious infection of the respiratory tract. Whooping cough can cause pneumonia, convulsions, brain damage, and even death.
  • TetanusBacteria enter the skin through cuts or grazes, and the toxins they produce can destroy the nervous system, causing widespread muscle pain and stiffness.
  • PolioPoliomyelitis is caused by the poliovirus, leading to paralysis of the limbs, and even death. Poliomyelitis can be transmitted through contact with the excrement of an infected person.
  • Haemophilus influenzae type b (Hib)can cause serious and life-threatening infectious diseases, including meningitis and septicaemia.
  • Hepatitis B: Transmitted via bodily fluids and blood, the hepatitis B virus can cause acute hepatitis. Common symptoms include fever, loss of appetite, nausea, vomiting, abdominal pain, yellowing of the whites of the eyes, dark-coloured urine, and stools that are clay-coloured or pale.Regardless of whether symptoms are present, approximately 5 to 10% of adult patients and 95% of infants infected by their mothers are unable to clear the virus, thereby becoming chronic carriers and potentially developing chronic hepatitis, permanent liver damage or liver cancer in the future.

六合一疫苗

Recommended vaccination time

  • 2 months, 4 months, 6 months, 15 to 18 months: four injections in total

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health

Benefits of the five-in-one vaccine

Combining multiple vaccines into a single injection greatly reduces the number of vaccinations, and can also lower the chances of side effects and discomfort in infants and young children after inoculation.

The five-in-one vaccine prevents diseases

  • DiphtheriaCaused by *Corynebacterium diphtheriae*, it is a serious bacterial infection affecting the nose and throat.
  • Whooping coughCaused by the bacterium pertussis, it is a serious infection of the respiratory tract. Whooping cough can cause pneumonia, convulsions, brain damage, and even death.
  • TetanusBacteria enter the skin through cuts or grazes, and the toxins they produce can destroy the nervous system, causing widespread muscle pain and stiffness.
  • PolioPoliomyelitis is caused by the poliovirus, leading to paralysis of the limbs, and even death. Poliomyelitis can be transmitted through contact with the excrement of an infected person.
  • Haemophilus influenzae type b (Hib)can cause serious and life-threatening infectious diseases, including meningitis and septicaemia.

五合一疫苗

Recommended vaccination time

  • 2 months, 4 months, 6 months, 15-18 months: 4 injections in total

The 5-in-1 and 6-in-1 are interchangeable.

This vaccineExcludingThe "Hong Kong Childhood Immunisation Programme" by the Centre for Health Protection of the Department of Health

What is *Haemophilus influenzae* type b?

Haemophilus influenzae type b Hi) is a bacterium that can cause serious invasive infections, with 90% of patients being under the age of 5, and the incidence being highest in those under the age of 2. Haemophilus influenzae type B can cause meningitis, pneumonia, pharyngitis, bacterial arthritis, and osteomyelitis. It is mainly transmitted through droplets from direct contact with a patient's nasal and pharyngeal secretions. All these conditions require prompt antibiotic treatment.

Haemophilus influenzae type b vaccine

Multiple countries, such as the USA, UK, Germany, Australia and Canada, have included the Hib vaccine in their universal healthcare vaccination programmes. However, the Hong Kong government has not yet included the Hib vaccine in its immunisation programme. To provide babies with comprehensive protection, parents can arrange for their children to be vaccinated at private clinics.

Recommended vaccination time

Generally speaking, it is recommended that children at 21 month, 4 months, 6 months, 18 monthsfour doses administered at the same time, currently available on the market:

  • Independent Haemophilus influenzae type b vaccine
  • Combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine – 5-in-1 vaccine
  • In addition to the five-in-one, plus the hepatitis B vaccine – Hexavalent vaccine

The main difference is the number of injections the child has to receive, and being able to get vaccinated all at once will cause the child less suffering.

What is pneumococcal disease?

The threat posed by pneumococcal bacteria to people worldwide is growing. Individuals of any age are susceptible to pneumococcal infections. Pneumococcal bacteria are highly contagious and can reside in the nasopharynx, lying in wait to invade the body and also spread to young children within the household. In addition to causing pneumonia, they can lead to various serious illnesses, such as pneumonia, meningitis, otitis media, and septicaemia, and can even be fatal.

 

13-valent pneumococcal conjugate vaccine

The World Health Organization states that vaccination is one of the most effective ways to prevent pneumococcal diseases. The combination of vaccine technologies can lead to immune memory, providing long-lasting protection. Individuals who have previously received the 7-valent or 10-valent pneumococcal vaccine can receive a booster dose of the 13-valent vaccine for broader protection. Preventable infectious diseases: Diseases caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.

Recommended vaccination time

13-valent pneumococcal vaccine Prevenar13 – Pfizer

  • 6 weeks – 6 months: 4 doses
  • 7 months to 11 months: 3 injections
  • 12–23 months: 2 doses
  • 2 years and over: 1 dose

Benefits of the 4-in-1 vaccine

The ones that currently require separate injectionsChickenpox jab and MMR (measles, mumps and rubella) jabBy combining these vaccines, the number of injections is reduced, whilst also providing effective protection against chickenpox, measles, mumps and rubella. As well as eliminating the need for two separate injections, the combined vaccine offers comprehensive protection for babies as early as 15 months of age, providing nearly 100% protection against chickenpox and sparing them the suffering caused by the disease.

Preventable diseases

  • ChickenpoxChickenpox is a common acute infectious disease in children, mostly occurring in those aged five to ten.
  • Measlescan cause fever, rash and cold-like symptoms, and can lead to ear infections or pneumonia.
  • MumpsIt causes fever, headaches, and swelling of the salivary glands and cheeks. More serious complications include encephalitis and temporary hearing loss.
  • Rubellacan cause serious complications and congenital defects in the fetus, including deafness, eye problems, heart defects, liver damage, and brain damage. This is also known as congenital rubella syndrome (CRS).

Recommended vaccination time

  • Aged 1 year and over: 2 doses (minimum 3 months between doses)

The benefits of the MMR vaccine.

MMR is currently administered as separate injectionsMeasles, mumps, and rubella vaccinecombined, reducing the number of injections required and effectively preventing measles, mumps, and rubella.

Preventable diseases

  • Measlescan cause fever, rash and cold-like symptoms, and can lead to ear infections or pneumonia.
  • MumpsIt causes fever, headaches, and swelling of the salivary glands and cheeks. More serious complications include encephalitis and temporary hearing loss.
  • Rubellacan cause serious complications and congenital defects in the fetus, including deafness, eye problems, heart defects, liver damage, and brain damage. This is also known as congenital rubella syndrome (CRS).

Chickenpox

Chickenpox is a highly contagious infectious disease caused by the varicella-zoster virus, which can be transmitted through respiratory droplets spread in the air by an infected person or through contact with the fluid from the blisters. Symptoms of the illness include fever and itchy rashes. The rashes typically appear progressively over about 5 days and then develop into itchy, bean-sized blisters. They initially appear on the skin of the head and face, then spread to the trunk and limbs, with the trunk usually having the most blisters. The small blisters will dry and scab over after about 3 days. Patients usually recover naturally within 2 to 4 weeks.

In healthy children, most chickenpox symptoms are mild. However, adults and those with weakened immune systems may experience more severe illness and complications, including skin inflammation, meningitis, encephalitis, and pneumonia. If pregnant women contract chickenpox in early pregnancy, it can lead to congenital defects in the foetus.

Chickenpox vaccine

Approximately 90% of people who receive the chickenpox vaccine develop immunity.

Recommended vaccination time

Suitable for ages 1 year and over: 2 doses (at least 3 months apart)

Shingles

Commonly known as "shingles", it is an illness caused by the chickenpox virus. Patients develop a painful, band-like rash with blisters. Anyone who has had chickenpox is at risk of developing shingles. If the virus affects the eyes or ears, it can even lead to blindness or deafness. It is estimated that about one-third of people may develop shingles in their lifetime, and it is common in the elderly or children.

95% of adults are at risk of developing ‘shingles’, and this risk increases significantly after the age of 50; one in three people will develop ‘shingles’ at some point in their lives, and it can be extremely painful!

Shingles vaccine

It can reduce the chance of getting the illness by half in those aged 50-80, and also helps reduce post-herpetic neuralgia or the severity of relapse. 

Influenza

Commonly known as "flu," it is an acute, contagious respiratory illness caused by viruses, primarily spread through droplets or secretions. Symptoms include fever, sore throat, and cough. While most cases resolve spontaneously within a week, complications such as viral pneumonia, bacterial pneumonia, sinusitis, or ear infections can occur, and in some instances, can be fatal. Influenza viruses mutate frequently, leading to seasonal epidemics. Therefore, the World Health Organization monitors circulating and newly discovered influenza strains and recommends the annual composition of the influenza vaccine. Annual vaccination against influenza is an effective method to prevent the flu and its associated complications.

Nasal spray flu vaccine (Flumist)

The new generation nasal flu vaccine, painlessly combats flu symptoms, suitable for the whole family!

噴鼻式流感疫苗

  • Painless intranasal drug delivery
  • Effective flu prevention
  • Reduce children's fear and discomfort
  • Quick process
  • For ages 2 to 49
  • The FDA has approved safety and efficacy.
  • Made in the USA

新一代噴鼻式流感疫苗

Recommended vaccination time

Age group

Have you been vaccinated?

Dose

Children aged 8 or under

Not vaccinated against influenza.
Has had the flu jab

Two doses (at least 4 weeks apart)
1 dose

Persons aged 9 and above

Whether or not you have been vaccinated against influenza

1 dose

*Information provided by the manufacturer

Flu

Peak infection periods: January to March, July and August annually

Quadrivalent flu vaccine

Parents and babies should both receive the seasonal influenza vaccine annually.

Recommended vaccination time

Suitable from 6 months of age

  • under 9 yearsNeverReceived flu vaccine: 2 doses (at least four weeks apart)
  • under 9 yearsUsedReceived flu vaccination: 1 dose
  • 9 years and over: 1 dose
 

Preventing influenza

To prevent influenza, in addition to getting vaccinated, it is important to maintain good personal hygiene. Wash your hands frequently, particularly before touching your mouth, nose or eyes, or after touching surfaces in public places (such as door handles and handrails). Where possible, use liquid soap and running water to wash your hands thoroughly.When your hands are not visibly soiled, using a hand sanitiser containing 70% – 80% alcohol is also an effective way to clean them.

Keep indoor air circulating. During influenza outbreaks, avoid crowded or poorly ventilated public places; high-risk individuals may consider wearing a mask when in such places. Maintain a balanced diet, regular exercise and adequate rest, do not smoke and avoid excessive life stress.

To be considerate of others, cover your mouth and nose when sneezing or coughing, and dispose of soiled tissues in a lidded bin. Wear a mask when experiencing respiratory symptoms.

Cervical cancer

It is not a genetic disorder. In 99.7% of cervical cancer cases worldwide, HPV (human papillomavirus) is found in every single case; it is the main cause of cervical cancer and can be transmitted even if the infected person shows no symptoms.

Cervical cancer vaccine

Effectively preventing HPV infection, protecting yourself and your partner, men and women should both take precautions! In addition, regular cervical cancer screening is one of the most effective ways to prevent cervical cancer.

嬰兒疫苗

Paediatric Vaccination Package

Paediatric specialist responsible for injections
✓ Paediatric Specialist Pre-vaccination Medical Examination
✓ Providing knowledge on care and medical aspects for infants and young children
✓ Help parents reduce concerns about caring for infants and young children
✓ All vaccinations are administered at Hui'er Clinic, no need to go to the health centre.

Option 1

Age/Year Group
Ages/Stages
Vaccinations to be administered
Types of vaccines
Newborn
Newborn
– Bacillus Calmette–Guérin (BCG) (given at birth)
– Hepatitis B vaccine – 1st dose (given at birth)
Six to eight weeks
6-8 weeks old
– 5-in-1 / 6-in-1 vaccine – 1st dose
– 13-valent pneumococcal vaccine – 1st dose
– Oral Rotavirus Vaccine – 1st Dose [Rotarix/Rotateq]
Four months
4 months old
– 5-in-1/6-in-1 vaccine – 2nd dose
– 13-valent pneumococcal vaccine – 2nd dose
– Oral rotavirus vaccine – 2nd dose [Rotarix/Rotateq]
Six months
6 months old
– 5-in-1/6-in-1 vaccine – 3rd dose
– 13-valent pneumococcal vaccine – 3rd dose
Oral Rotavirus Vaccine – 3rd Dose [Rotateq]
Nine months
9 months old
– MenACWY conjugate vaccine – 1st dose
– Japanese Encephalitis Vaccine – 1st dose
One year old
1 year old
– Combined measles, mumps, rubella and varicella vaccine (MMRV) – 1st dose
– 13-valent pneumococcal vaccine – booster dose
Fifteen months
15 months old
– Meningococcal ACWY conjugate vaccine (ACWY) – 2nd dose
Hepatitis A vaccine – 1st dose
Eighteen months
18 months old
– 5-in-1 vaccine – booster dose
– MMRV vaccine – 2nd dose
Twenty-four months
24 months old
Hepatitis A vaccine – 2nd dose
– Japanese Encephalitis Vaccine – 2nd dose
Twenty-seven months
27 months
– Meningococcal B vaccine (Men-B) – First dose
Thirty months
30 months old
– Meningococcal B vaccine (Men-B) – 2nd dose


Option 2

 

Age/Year Group
Ages/Stages
Vaccinations to be administered
Types of vaccines
Newborn
Newborn
– Bacillus Calmette–Guérin (BCG) (given at birth)
– Hepatitis B vaccine – 1st dose (given at birth)
Six to eight weeks
6-8 weeks old
– 5-in-1 / 6-in-1 vaccine – 1st dose
– 13-valent pneumococcal vaccine – 1st dose
– Oral Rotavirus Vaccine – 1st Dose [Rotarix/Rotateq]
Three months
3 months old
– Quadrivalent meningococcal conjugate vaccine (ACWY) – Nimenrix dose 1
– Meningococcal group B vaccine (Men-B) – Bexsero 1st dose
Four months
4 months old
– 5-in-1/6-in-1 vaccine – 2nd dose
– 13-valent pneumococcal vaccine – 2nd dose
– Oral rotavirus vaccine – 2nd dose [Rotarix/Rotateq]
Five months
5 months old
– Meningococcal ACWY conjugate vaccine (ACWY) – Nimenrix 2nd dose
– Meningococcal B vaccine (Men-B) – Bexsero 2nd dose
Six months
6 months old
– 5-in-1/6-in-1 vaccine – 3rd dose
– Oral Rotavirus Vaccine – 3rd Dose (Rotateq)
Nine months
9 months old
– Japanese Encephalitis Vaccine – 1st dose
One year old
1 year old
– Combined measles, mumps, rubella and varicella vaccine (MMRV) – 1st dose
– 13-valent pneumococcal vaccine – booster dose
Thirteen to fifteen months
13-15 months old
Quadrivalent meningococcal conjugate vaccine (ACWY) - Nimenrix 3rd dose
– Meningitis B vaccine (Men-B) – Bexsero 3rd dose
Eighteen months
18 months old
– 5-in-1 vaccine – booster dose
– MMRV vaccine – 2nd dose
2 years oldHepatitis A vaccine – 1st dose
– Japanese Encephalitis Vaccine – 2nd dose
Thirty months
30 months old
Hepatitis A vaccine – 2nd dose
Age/Year Group
Ages/Stages
Vaccinations to be administered
Types of vaccines
Six to eight weeks
6-8 weeks old
— Hexavalent Vaccine – First Dose
– 15/20-valent pneumococcal vaccine – first dose
Rotavirus oral vaccine – First dose (Rotarix/Rotateq)
Three months

3 months old

Meningococcal ACWY conjugate vaccine (ACWY) Nimenrix – First dose
– Meningococcal B vaccine (Bexsero) – First dose
Four months
4 months old
Five-in-one vaccine - Second dose
– 15/20-valent pneumococcal vaccine – second dose
– Oral Rotavirus Vaccine – Second Dose (Rotarix/Rotateq)
Five months

5 months old

– Quadrivalent meningococcal conjugate vaccine (ACWY) Nimenrix – Second dose
- Meningococcal group B conjugate vaccine (Bexsero) - Second dose
Six months

6 months old

– Five-in-one vaccine – Third dose
– 15/20-valent pneumococcal vaccine – third dose
Oral Rotavirus Vaccine – Third Dose (Rotarix)
Nine months

9 months old

Japanese encephalitis vaccine – 1st dose
Twelve months

12 months old

MMRV vaccine - 4 doses, 1st time
Pneumococcal vaccine (13-valent) – booster dose
Thirteen to fifteen months

13 – 15 months old

Meningococcal ACWY conjugate vaccine (ACWY) Nimenrix – third dose
- Meningococcal Group B Vaccine (Bexsero) - Third dose
Eighteen months

18 months old

Five-in-one vaccine – booster
Four-in-one vaccine (MMRV) – Second dose
Twenty-four months

24 months old

Japanese encephalitis vaccine – second dose
Thirty months

30 months old

Hepatitis A vaccine – second dose
Ages/Years Vaccine types
Six to eight weeks old
— Hexavalent Vaccine – First Dose
– 15/20-valent pneumococcal vaccine – first dose
Rotavirus oral vaccine – First dose (Rotarix/Rotateq)
Four months
Five-in-one vaccine - Second dose
– 15/20-valent pneumococcal vaccine – second dose
– Oral Rotavirus Vaccine – Second Dose (Rotarix/Rotateq)
Six months
6 months old
– Five-in-one vaccine – Third dose
– 15/20-valent pneumococcal vaccine – third dose
- Meningococcal B-conjugate vaccine (Bexsero) - First dose
Oral Rotavirus Vaccine – Third Dose (Rotarix)
NineMonth
9 months old
- Meningococcal B conjugate vaccine (Bexsero) - Second dose - Japanese encephalitis vaccine - First dose
TwelveMonth
12 months old
MMRV vaccine - 4 doses, 1st time
Pneumococcal vaccine (13-valent) – booster dose
Thirteen to fifteen months
13 – 15 months old
– Meningococcal ACWY conjugate vaccine (ACWY) Menactra/Nimenrix – First dose
- Meningococcal Group B Vaccine (Bexsero) - Third dose
Hepatitis A vaccine - First jab
Eighteen months
18 months old
Five-in-one vaccine – booster
Four-in-one vaccine (MMRV) – Second dose
Twenty-four months
24 months old
Japanese encephalitis vaccine – second dose
Hepatitis A vaccine – second dose
Age/Year Group
Ages/Stages
Vaccinations to be administered
Types of vaccines
Six to eight weeks
6-8 weeks old
— Hexavalent Vaccine – First Dose
– 15/20-valent pneumococcal vaccine – first dose
Rotavirus oral vaccine – First dose (Rotarix/Rotateq)
Three months

3 months old

Meningococcal ACWY conjugate vaccine (ACWY) Nimenrix – First dose
– Meningococcal B vaccine (Bexsero) – First dose
Four months
4 months old
Five-in-one vaccine - Second dose
– 15/20-valent pneumococcal vaccine – second dose
Oral rotavirus vaccine – second dose (Rotarix/Rotateq)
Five months

5 months old

– Quadrivalent meningococcal conjugate vaccine (ACWY) Nimenrix – Second dose
- Meningococcal group B conjugate vaccine (Bexsero) - Second dose
Six months

6 months old

– Five-in-one vaccine – Third dose
– 15/20-valent pneumococcal vaccine – third dose
Oral Rotavirus Vaccine – Third Dose (Rotarix)
Nine months

9 months old

Japanese Encephalitis Vaccine – First Dose
Twelve months

12 months old

MMRV vaccine - 4 doses, 1st time
Pneumococcal vaccine (13-valent) – booster dose
Thirteen to fifteen months

13 – 15 months old

Meningococcal ACWY conjugate vaccine (ACWY) Nimenrix – third dose
- Meningococcal Group B Vaccine (Bexsero) - Third dose
Eighteen months

18 months old

Five-in-one vaccine – booster
– 4-in-1 vaccine MMRV – second dose
Twenty-four months
24 months old
Japanese encephalitis vaccine – second dose
Ages/Years Vaccine types
Six to eight weeks old
— Hexavalent Vaccine – First Dose
– 15/20-valent pneumococcal vaccine – first dose
Rotavirus oral vaccine – First dose (Rotarix/Rotateq)
fourMonth
4 months old
Five-in-one vaccine - Second dose
– 15/20-valent pneumococcal vaccine – second dose
Oral rotavirus vaccine – second dose (Rotarix/Rotateq)
SixMonth
6 months old
– Five-in-one vaccine – Third dose
– 15/20-valent pneumococcal vaccine – third dose
Meningococcal B vaccine (Bexsero) - First dose
Oral Rotavirus Vaccine – Third Dose (Rotarix)
Nine months
9 months old
Bexsero - Meningococcal Group B Conjugate Vaccine - Second Dose
Japanese Encephalitis Vaccine – First Dose
Twelve months
12 months old
MMRV vaccine - 4 doses, 1st time
Pneumococcal vaccine (13-valent) – booster dose
Thirteen to fifteen months
13 – 15 months old
Meningococcal ACWY conjugate vaccine (ACWY) Menactra/Nimenrix – First dose
- Meningococcal Group B Vaccine (Bexsero) - Third dose
Eighteen months
18 months old
Five-in-one vaccine – booster
– 4-in-1 vaccine MMRV – second dose
 Twenty-four months
24 months old
Japanese encephalitis vaccine – second dose
Age/Year Group
Ages/Stages
Vaccinations to be administered
Types of vaccines
Six to eight weeks
6-8 weeks old
— Hexavalent Vaccine – First Dose
– 15/20-valent pneumococcal vaccine – first dose
Rotavirus oral vaccine – First dose (Rotarix/Rotateq)
ThreeMonth

3 months old

Meningococcal ACWY conjugate vaccine (ACWY) Nimenrix – First dose
– Meningococcal B vaccine (Bexsero) – First dose
fourMonth

4 months old

Five-in-one vaccine - Second dose
– 15/20-valent pneumococcal vaccine – second dose
– Oral Rotavirus Vaccine – Second Dose (Rotarix/Rotateq)
FiveMonth

5 months old

– Quadrivalent meningococcal conjugate vaccine (ACWY) Nimenrix – Second dose
- Meningococcal group B conjugate vaccine (Bexsero) - Second dose
Six months

6 months old

– Five-in-one vaccine – Third dose
– 15/20-valent pneumococcal vaccine – third dose
Oral Rotavirus Vaccine – Third Dose (Rotarix)
Twelve months

12 months old

MMRV vaccine - 4 doses, 1st time
Pneumococcal vaccine (13-valent) – booster dose
Thirteen to fifteen months

13 – 15 months old

Meningococcal ACWY conjugate vaccine (ACWY) Nimenrix – third dose
- Meningococcal Group B Vaccine (Bexsero) - Third dose
Eighteen months

18 months old

Five-in-one vaccine – booster
– 4-in-1 vaccine MMRV – second dose
Age/Year Group
Ages/Stages
Vaccinations to be administered
Types of vaccines
Six to eight weeks
6-8 weeks old
— Hexavalent Vaccine – First Dose
– 15/20-valent pneumococcal vaccine – first dose
Rotavirus oral vaccine – First dose (Rotarix/Rotateq)
fourMonth

4 months old

Five-in-one vaccine - Second dose
– 15/20-valent pneumococcal vaccine – second dose
Oral rotavirus vaccine – second dose (Rotarix/Rotateq)
Six months

6 months old

Hexavalent vaccine – third dose
– 15/20-valent pneumococcal vaccine – third dose
Meningococcal B vaccine (Bexsero) - First dose
Oral Rotavirus Vaccine – Third Dose (Rotarix)
NineMonth

9 months old

- Meningococcal group B conjugate vaccine (Bexsero) - Second dose
 Twelve months

12 months old

MMRV vaccine - 4 doses, 1st time
Pneumococcal vaccine (13-valent) – booster dose
Thirteen to fifteen months

13 – 15 months old

Meningococcal ACWY conjugate vaccine (ACWY) – Menactra/Nimenrix – First dose
- Meningococcal Group B Vaccine (Bexsero) - Third dose
 Eighteen months
18 months old
Five-in-one vaccine – booster
– 4-in-1 vaccine MMRV – second dose

This Paediatric Medical Centre also offers a range of child vaccination programmes, allowing parents to choose the most suitable plan for their baby. Details can be discussed with a paediatric specialist.

兒童過敏常見問題

Common Questions

As recommended by the Scientific Committee on Vaccines Preventable Diseases under the Centre for Health Protection of the Department of Health, "Hong Kong Childhood Immunisation ProgrammeFrom birth to the end of primary school (Year 6), children need to be vaccinated with different types of vaccines and boosters to prevent eleven infectious diseases: tuberculosis, poliomyelitis, hepatitis B, diphtheria, pertussis, tetanus, pneumococcal infection, chickenpox, measles, mumps, and rubella.

Children from birth to five years of age can receive immunisations at Maternal and Child Health Centres under the Department of Health, accompanied by their parents. For primary school pupils, Department of Health vaccinators will visit their schools to provide immunisation services.Parents can also choose to have their children vaccinated at a private doctor's clinic..

Private clinics and hospitals also offer other vaccinations for children to prevent relevant infectious diseases and protect individual health. These include the influenza vaccine, *Haemophilus influenzae* type b (Hib) vaccine, meningococcal vaccine, hepatitis A vaccine, and Japanese encephalitis vaccine, among others.

If parents wish to have their children vaccinated with these vaccines, they should first consult a private doctor. The doctor will provide appropriate advice based on the child's individual circumstances.

Generally speaking, if a child has mild discomfort such as a runny nose, but other behaviours such as eating, playing, resting and bowel habits are normal, the child can receive immunisation. If parents are still concerned, they can postpone the vaccination for a few days to allow sufficient time to observe the child's condition. If a child has a fever, they should first seek medical attention at a general outpatient clinic or private clinic, and only be vaccinated after they have recovered.

If a child has any of the following conditions, they may not be suitable for vaccination. You should consult a doctor before vaccination:

  1. Any condition that weakens the immune system, such as:
    Congenital immune deficiency
    – Contracted leukaemia, tumours
    – Requires long-term medication or treatment, such as undergoing radiotherapy, chemotherapy, or taking steroids
  2. Have you had any serious reactions after your last vaccination?
  3. To have had a severe allergic reaction to certain antibiotics or other substances
  4. Circumstances where vaccination is considered unsuitable following a doctor's diagnosis

Children generally have mild reactions after vaccination, such as being irritable, having a slight fever, and experiencing mild redness, swelling, or pain at the injection site.

Parents can freeze a towel and apply it to the injection site to reduce pain.

If any adverse reactions persist or worsen, for example, if restlessness continues for more than 24 hours, if fever reaches 40°C (104°F) or above, or if swelling and pain at the injection site do not subside after 24 hours or instead increase, you should consult a doctor.

You should seek immediate medical attention if the following situations arise.:

    • Less common occurrences – continuous crying for 3 hours or more, febrile seizures or shock (hypotonic hyporesponsive episode), etc.
    • Relatively rare occurrence – temporary swelling of the upper arm after vaccination
    • Extremely rare – difficulty breathing or loss of consciousness immediately after vaccination

Enquiry about childhood vaccination programme

Our centre will contact you to confirm the details before confirming the reservation.
Required
Scroll to Top

Keep up with the latest information on the epidemic and children's health?
Subscribe to our regular emails now

To be completed
建立注射疫苗時間表
即時預約
whatsapp預約
網上預約